Patient selection for bevacizumab therapy has changed since its FDA approval. In this video blog, Dr. Mark Kris addresses the absolute and relative contraindications to the use of this drug. Medscape Hematology-Oncology
Commentary on a study on the role of FDG PET-CT in the differential diagnosis of ascites, published April 2009 in the Journal of Nuclear Medicine. Medscape Radiology
Annual mammograms beginning at age 40 -- as recommended by the American Cancer Society -- would greatly reduce the risk for mastectomy in women between 40 and 50 years of age. Medscape Medical News
French researchers report poor survival rates for patients with localized prostate cancer treated with high-intensity focused ultrasound (HIFU) delivered by second-generation Ablatherm equipment. Medscape Urology
